Comerica Securities’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Comerica Securities's RGEN Position: Q1 2023 in Review
Comerica Securities sold out of Repligen (RGEN) in Q1 2023, closing a stake of 294 shares — an estimated $49.8K sold.
Comerica Securities first reported a position in RGEN in Q3 2021 and held it in 3 quarters. The position peaked at $236K in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.
- Comerica Securities reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
- Comerica Securities sold 294 Repligen shares in Q1 2023, an estimated $49.8K.
- Comerica Securities first reported a position in Repligen in Q3 2021 and held it in 3 quarters.
- Comerica Securities's Repligen position peaked at $236K in Q3 2021.
- 446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.
Based on Comerica Securities's 13F filing for Q1 2023, filed 27 Apr 2023.